Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: Analysis of regions critical for glycoprotein aggregation and CD81 binding

Journal of General Virology

Volumn 81, Issue 12, 2000, Pages 2873-2883

  Patel, A H ^a   Wood, J ^a   Penin, F ^a   Dubuisson, J ^a   McKeating, J A ^a  

^a INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD81 ANTIGEN; CHIMERIC PROTEIN; DISULFIDE; MONOCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGENICITY; ARTICLE; CELL STRAIN BHK; CONTROLLED STUDY; GENOTYPE; HEPATITIS C VIRUS; KIDNEY CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; VIRUS TYPING;

EID: 0034536336     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-12-2873     Document Type: Article

References (46)

1. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
2. MPSA: Integrated system for multiple protein sequence analysis with client/ server capabilities
3. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa
4. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral-hepatitis genome
5. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins
6. Molecular virology of hepatitis C virus
7. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2
8. NPS@: Network protein sequence analysis
9. New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins
10. Formation of native hepatitis C virus glycoprotein complexes
11. Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin
12. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
13. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
14. The role of hepatitis C virus glycoproteins in infection
15. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
16. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein
17. Why mammalian cell surface proteins are glycoproteins
18. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties
19. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
20. Hepatitis C viruses
21. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses
22. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA
23. Global surveillance and control of hepatitis C
24. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
25. Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein
26. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells
27. Characterization of truncated forms of hepatitis C virus glycoproteins
28. Two hepatitis C virus glycoprotein E2 products with different C termini
29. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
30. Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2
31. Improved tools for biological sequence comparison
32. Binding of hepatitis C virus to CD81
33. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
34. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization
35. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
36. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells
37. Virus-encoded proteinases of the Flaviviridae
38. Complex processing and protein-protein Interactions in the E2-Ns2 region of HCV
39. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
40. Variability of hepatitis C virus
41. A proposed system for the nomenclature of hepatitis C viral genotypes
42. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
43. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
44. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and Ns1 proteins and the pestivirus envelope glycoproteins
45. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
46. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment